Chinese Medicine

Chinese Medicine (CHIN MED-UK, ISSN: 1749-8546) is a premier, peer-reviewed open access journal published by BioMed Central (Springer Nature). With an Impact Factor of 7.400 in 2026 and a JCR Quartile ranking of Q1, the journal occupies a top-tier position in its field, reflecting its significant influence and high citation impact within the global research community. The journal’s scope encompasses all aspects of traditional Chinese medicine (TCM) and its modernization, including but not limited to herbal medicine, acupuncture, pharmacognosy, phytochemistry, pharmacology, and clinical applications. It serves as a vital interdisciplinary platform for bridging ancient medical wisdom with contemporary scientific methodologies. Chinese Medicine publishes a wide array of article types, including original research articles, comprehensive reviews, methodological papers, short communications, and commentaries. Its target audience comprises academic researchers, clinicians, pharmacologists, pharmaceutical scientists, and healthcare professionals interested in the evidence-based validation and integration of Chinese medicine into mainstream healthcare. A notable feature is its open access model, ensuring that all published content is freely and permanently accessible online, which maximizes the visibility and dissemination of research findings worldwide. As a Q1 journal with an impact factor well above the average in its category, Chinese Medicine is widely recognized as a leading authoritative source for high-quality, rigorous research that advances the scientific understanding and clinical application of traditional Chinese medicine on an international stage.